Operative modification for the prevention of device-related infection during NIPRO extracorporeal left ventricular assist device implantation

Tomoki Ushijima, Yoshihisa Tanoue, Hirofumi Onitsuka, Atsuhiro Nakashima, Ryuji Tominaga

Research output: Contribution to journalArticle

Abstract

An operative modification in which the NIPRO left ventricular assist device (LVAD) cannulas are passed through the intraperitoneal cavity is performed as the firstchoice standard technique in our institution. Eighteen consecutive patients who underwent NIPRO LVAD implantation as heart transplantation candidates were enrolled in this study. The cannulas were passed through the intraperitoneal cavity in 11 patients (Group IP) and the extraperitoneal space in 7 patients (Group EP). A devicerelated major infection was defined as bloodstream infection and/or abscess formation in the deep tissue space. Device-related major infection occurred in 6 patients in Group IP and in 6 patients in Group EP. Of these patients, 3 patients in Group IP and 5 patients in Group EP suffered from uncontrollable bloodstream infection and finally died of development into multiple organ failure and/or cerebrovascular accidents. The actuarial rates of freedom from device-related major infection at 6 months after LVAD implantation were 100 % in Group IP and 38 % in Group EP, respectively (p = 0.02). Moreover, the actuarial survival rates after the initial device-related major infection in Group IP could be significantly higher than in Group EP (83 and 67 % at 6 months, p = 0.03). We demonstrated that this operative modification can contribute to prevention of progression of superficial skin infection to critical infection and to extension of the survival duration after the initial device-related major infection.

Original languageEnglish
Pages (from-to)220-227
Number of pages8
JournalJournal of Artificial Organs
Volume17
Issue number3
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Equipment and Supplies
Infection
Skin
Accidents
Tissue
Multiple Organ Failure
Heart Transplantation
Abscess
Survival Rate
Stroke

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Cite this

Operative modification for the prevention of device-related infection during NIPRO extracorporeal left ventricular assist device implantation. / Ushijima, Tomoki; Tanoue, Yoshihisa; Onitsuka, Hirofumi; Nakashima, Atsuhiro; Tominaga, Ryuji.

In: Journal of Artificial Organs, Vol. 17, No. 3, 01.01.2014, p. 220-227.

Research output: Contribution to journalArticle

@article{d0308ce2d5ab410f84276dae18a09f49,
title = "Operative modification for the prevention of device-related infection during NIPRO extracorporeal left ventricular assist device implantation",
abstract = "An operative modification in which the NIPRO left ventricular assist device (LVAD) cannulas are passed through the intraperitoneal cavity is performed as the firstchoice standard technique in our institution. Eighteen consecutive patients who underwent NIPRO LVAD implantation as heart transplantation candidates were enrolled in this study. The cannulas were passed through the intraperitoneal cavity in 11 patients (Group IP) and the extraperitoneal space in 7 patients (Group EP). A devicerelated major infection was defined as bloodstream infection and/or abscess formation in the deep tissue space. Device-related major infection occurred in 6 patients in Group IP and in 6 patients in Group EP. Of these patients, 3 patients in Group IP and 5 patients in Group EP suffered from uncontrollable bloodstream infection and finally died of development into multiple organ failure and/or cerebrovascular accidents. The actuarial rates of freedom from device-related major infection at 6 months after LVAD implantation were 100 {\%} in Group IP and 38 {\%} in Group EP, respectively (p = 0.02). Moreover, the actuarial survival rates after the initial device-related major infection in Group IP could be significantly higher than in Group EP (83 and 67 {\%} at 6 months, p = 0.03). We demonstrated that this operative modification can contribute to prevention of progression of superficial skin infection to critical infection and to extension of the survival duration after the initial device-related major infection.",
author = "Tomoki Ushijima and Yoshihisa Tanoue and Hirofumi Onitsuka and Atsuhiro Nakashima and Ryuji Tominaga",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s10047-014-0766-0",
language = "English",
volume = "17",
pages = "220--227",
journal = "Journal of Artificial Organs",
issn = "1434-7229",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Operative modification for the prevention of device-related infection during NIPRO extracorporeal left ventricular assist device implantation

AU - Ushijima, Tomoki

AU - Tanoue, Yoshihisa

AU - Onitsuka, Hirofumi

AU - Nakashima, Atsuhiro

AU - Tominaga, Ryuji

PY - 2014/1/1

Y1 - 2014/1/1

N2 - An operative modification in which the NIPRO left ventricular assist device (LVAD) cannulas are passed through the intraperitoneal cavity is performed as the firstchoice standard technique in our institution. Eighteen consecutive patients who underwent NIPRO LVAD implantation as heart transplantation candidates were enrolled in this study. The cannulas were passed through the intraperitoneal cavity in 11 patients (Group IP) and the extraperitoneal space in 7 patients (Group EP). A devicerelated major infection was defined as bloodstream infection and/or abscess formation in the deep tissue space. Device-related major infection occurred in 6 patients in Group IP and in 6 patients in Group EP. Of these patients, 3 patients in Group IP and 5 patients in Group EP suffered from uncontrollable bloodstream infection and finally died of development into multiple organ failure and/or cerebrovascular accidents. The actuarial rates of freedom from device-related major infection at 6 months after LVAD implantation were 100 % in Group IP and 38 % in Group EP, respectively (p = 0.02). Moreover, the actuarial survival rates after the initial device-related major infection in Group IP could be significantly higher than in Group EP (83 and 67 % at 6 months, p = 0.03). We demonstrated that this operative modification can contribute to prevention of progression of superficial skin infection to critical infection and to extension of the survival duration after the initial device-related major infection.

AB - An operative modification in which the NIPRO left ventricular assist device (LVAD) cannulas are passed through the intraperitoneal cavity is performed as the firstchoice standard technique in our institution. Eighteen consecutive patients who underwent NIPRO LVAD implantation as heart transplantation candidates were enrolled in this study. The cannulas were passed through the intraperitoneal cavity in 11 patients (Group IP) and the extraperitoneal space in 7 patients (Group EP). A devicerelated major infection was defined as bloodstream infection and/or abscess formation in the deep tissue space. Device-related major infection occurred in 6 patients in Group IP and in 6 patients in Group EP. Of these patients, 3 patients in Group IP and 5 patients in Group EP suffered from uncontrollable bloodstream infection and finally died of development into multiple organ failure and/or cerebrovascular accidents. The actuarial rates of freedom from device-related major infection at 6 months after LVAD implantation were 100 % in Group IP and 38 % in Group EP, respectively (p = 0.02). Moreover, the actuarial survival rates after the initial device-related major infection in Group IP could be significantly higher than in Group EP (83 and 67 % at 6 months, p = 0.03). We demonstrated that this operative modification can contribute to prevention of progression of superficial skin infection to critical infection and to extension of the survival duration after the initial device-related major infection.

UR - http://www.scopus.com/inward/record.url?scp=84929941604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929941604&partnerID=8YFLogxK

U2 - 10.1007/s10047-014-0766-0

DO - 10.1007/s10047-014-0766-0

M3 - Article

C2 - 24723254

AN - SCOPUS:84929941604

VL - 17

SP - 220

EP - 227

JO - Journal of Artificial Organs

JF - Journal of Artificial Organs

SN - 1434-7229

IS - 3

ER -